Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy

Int J Tuberc Lung Dis. 2009 Aug;13(8):925-6.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Antitubercular Agents / therapeutic use*
  • Comorbidity
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • Humans
  • Isoniazid / therapeutic use*
  • Public Health
  • Tuberculosis / epidemiology*
  • Tuberculosis / prevention & control*

Substances

  • Anti-Retroviral Agents
  • Antitubercular Agents
  • Isoniazid